Afya announces resignation of Board member Shobhna Mohn

Afya, a Brazilian medical education group, has announced that Shobhna Mohn has resigned from its Board of Directors, effective 30 June. 

The resignation coincides with Mohn stepping down from her operational role at Bertelsmann, one of Afya’s key shareholders. 

In a press release, Afya said, “Mrs. Mohn's decision is unrelated to any matter associated with the Company, its operations, policies, or practices.”

Virgilio Gibbon, Afya’s CEO, said:

"As CEO, I sincerely thank Mrs. Mohn for her invaluable contributions and solid dedication to our Company. Her strategic insights and leadership have been fundamental in our growth and success. We wish her all the best in her future endeavours and remain grateful for her lasting impact on our organisation," 

Reflecting on her tenure, Shobhna Mohn stated:

 “It has been a privilege and an honour to be part of building Afya, working with some of the best investors, board members and management in the industry, seeing it list on Nasdaq in 2019, and becoming an industry reference in a key and impactful sector while spearheading innovation. 

“For me personally, it was a great way to get introduced to the Brazilian Market with exemplary structures when it comes to quality medical education. I wish everyone in the Board and Management continued success and impact and will certainly miss our regular exchanges.”

Afya also announced that there are no immediate plans for Bertelsmann SE&Co. KGaA to appoint a new member to replace Mohn on the Board of Directors. 

The current Afya Board of Directors includes two co-chairmen, representatives from Bertelsmann SE&Co. KGaA and the Esteves family, a member from Softbank, and four independent members.